Clinton Health Access Initiative will use award to expand access to SCD diagnostic tests and treatment in low- and ...
Wilson celebrates the first U.S. patient to complete gene therapy for sickle cell, but says advocacy must continue.
It may be possible to collect nearly three times as many stem cells for sickle cell gene therapy with motixafortide than standard plerixafor.
A University of Rochester hospital will open a patient study comparing the efficacy of SCD treatments to help families in ...
In a society that often treats those living with a disability as "less than," columnist Mary Shaniqua reminds her community ...
BEAM-101, a gene-editing stem cell therapy, showed early signs of efficacy among the first treated sickle cell patients in a ...